Ledger.Open graph →
SEC Form D · filed October 18, 2022

RheumaGen, Inc

Offering
$2.0M
Sold
$2.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DENVER, CO
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (15)

Gregory L. Andrews · Denver, CODirectorRichard A. Freed, Iii · Denver, COExec · DirectorBrian M. Freed · Denver, COExec · DirectorJames B. Hart, Jr · Denver, COExecRyan K. Hart · Denver, COExecMark Bell · Atlanta, GADirectorBenton Heinzelmann · Fort Worth, TXExecChristine Thompson · Atlanta, GAExecPeter Clarke · Vancouver, British Columbia, CanadaExec · DirectorRodney M. Hamilton · Franklin, TNExec · DirectorBrenton Fargnoli · Nashville, TNExecVijay Patel · Nashville, TNExecTcim GP LLC · New York, NYDirectorHollie Haynes · SAN FRANCISCO, CAExec · DirectorGerard J. Frigon · Scottsdale, AZExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗